CSL finally scores $2.3bn rare disease drug deal
SYDNEY: Australian biotech giant CSL has agreed to pay as much as $US1.6 ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
FEATURED
Court filings reveal SkyCity gambler’s $4.5b China debts
The Lottery Corporation adds 2% as shares turn higher
National wagering spend declines despite growth in gambling market
Australia now set to bar celebrities from gambling ads in 2027
Dazn seeks to calm staff jitters amid questions over Foxtel future